Acutus Medical, Inc. (AFIB)
OTCMKTS: AFIB · Delayed Price · USD
0.0590
+0.0140 (31.11%)
May 17, 2024, 3:49 PM EDT - Market closed
Acutus Medical Revenue
Acutus Medical had revenue of $6.62M in the twelve months ending March 31, 2024, down -60.72% year-over-year. Revenue in the quarter ending March 31, 2024 was $3.63M, a -13.07% decrease year-over-year. In the year 2023, Acutus Medical had annual revenue of $7.16M, a decrease of -56.22%.
Revenue (ttm)
$6.62M
Revenue Growth
-60.72%
P/S Ratio
0.26
Revenue / Employee
$28,783
Employees
230
Market Cap
1.75M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.16M | -9.20M | -56.22% |
Dec 31, 2022 | 16.36M | -900.00K | -5.21% |
Dec 31, 2021 | 17.26M | 8.80M | 103.96% |
Dec 31, 2020 | 8.46M | 5.63M | 198.45% |
Dec 31, 2019 | 2.84M | 670.00K | 30.93% |
Dec 31, 2018 | 2.17M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 379.49B |
Johnson & Johnson | 81.80B |
Merck & Co. | 61.40B |
AbbVie | 54.40B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Abbott Laboratories | 40.33B |
AFIB News
- 9 days ago - Acutus Medical Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 6 months ago - Top 4 Health Care Stocks That Could Blast Off This Quarter - Acutus Medical (NASDAQ:AFIB), Becton Dickinson (NYSE:BDX) - Benzinga
- 6 months ago - Acutus Medical to Cancel Third Quarter 2023 Conference Call - GlobeNewsWire
- 6 months ago - Acutus Medical Reports Third Quarter 2023 Financial Results - GlobeNewsWire
- 6 months ago - Acutus Medical Announces Strategic Realignment of Resources and Corporate Restructuring - GlobeNewsWire
- 7 months ago - Acutus Medical to Announce Third Quarter 2023 Financial Results - GlobeNewsWire
- 7 months ago - Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire